Risk of Endometrial Cancer Following Estrogen Replacement With and Without Progestins

1999472 citationsJournal Articlebronze Open Access

Authors

Elisabete Weiderpass · Karolinska Institutet

Hans‐Olov Adami · Harvard University Press

John A. Baron · Dartmouth College

Cecilia Magnusson · Karolinska Institutet

R. Bergström

Anders Lindgren

N. Correia · Karolinska Institutet

Ingemar Persson ·

Abstract

The risk of developing endometrial cancer is increased after long-term use of estrogens without progestins and with cyclically added progestins. Continuously added progestins may be needed to minimize the endometrial cancer risk associated with estrogen replacement therapy.

Topics & Keywords

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: JNCI Journal of the National Cancer Institute

Volume 91, Issue 13, pp. 1131-1137

DOI: 10.1093/jnci/91.13.1131

Field-Weighted Citation Impact: 20.04